$2.09
+0.0 (+0.0%)
2
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$104.8M
ROE
-44.8%
D/E
0.00
Beta
0.40
52W
$1–$2
Wall Street Consensus
7 analysts · Dec 20250
Strong Buy
0
Buy
4
Hold
1
Sell
2
Strong Sell
0.0%
Buy Rating
Price Chart
Similar Stocks
SGMO
Sangamo Therapeutics Inc
$141.3M
BMEA
Biomea Fusion Inc
$87.7M
KPTI
Karyopharm Therapeutics Inc
$125.5M
CRDF
Cardiff Oncology Inc
$189.3M
CADL
Candel Therapeutics Inc
$310.2M
ALDX
Aldeyra Therapeutics Inc
$99.9M
SPRB
Spruce Biosciences, Inc
$93.2M
COYA
Coya Therapeutics Inc
$121.4M
QTTB
Q32 Bio Inc
$40.9M
PYXS
Pyxis Oncology Inc
$71.6M
Earnings
Beat rate: 50.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Jun 2025 | $-0.14 | $-0.11 | +$0.03 |
| Mar 2025 | $-0.37 | $-0.12 | +$0.25 |
| Dec 2024 | $-0.33 | $-0.68 | $-0.35 |
| Sep 2024 | $-0.43 | $-0.52 | $-0.09 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -44.8% | -44.6% | -44.8% | -44.8% | -44.8% | -44.8% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 26.39 | 26.39 | 26.39 | 26.39 | 26.39 | 26.39 |
Key Ratios
ROA (TTM)
-37.2%
P/B
0.7
EPS (TTM)
$-1.44
CF/Share
$-2.82
52W High
$2.17
52W Low
$1.34
$1.34
52-Week Range
$2.17
How does HLVX compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
HLVX valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
0.7
▼
73%
below
peers
(2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
HLVX profitability vs Biotechnology peers
ROE
-44.8%
▲
33%
above
peers
(-67.3%)
vs Peers
vs Industry
Below avg
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-37.2%
▲
20%
above
peers
(-46.7%)
vs Peers
vs Industry
Below avg
HLVX financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
26.4
▲
494%
above
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
0.4
▼
59%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
HLVX fundamentals radar
HLVX
Peer median
Industry
HLVX profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
HLVX vs peers: key metrics
Latest News
No related news yet